Controlled Release Drug Delivery Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Controlled release drug delivery systems are used by physicians in order to allow reduced amount of dose and dosage frequency, enhanced less fluctuation in plasma drug levels, uniform drug effect, patient compliance and acceptance. Wurster coating is the one of the oldest technology being used for controlled release of drug since 1976. There are few new controlled-release drug delivery technologies are expected to be in commercialization phase in next few years. For instance, MicroCor PTH using MicroCor transdermal technology, in phase IIa. Oral controlled drug delivery systems are generally helpful for elderly and pediatric population. Commercially available medications using controlled-release drug delivery technology include Avinza (polymer coating), Alza (osmotically activated system), Capoten (enzyme activated system), GLUCOPHAGE XR (polymer matrix based system), Prozac (polymer matrix based system), etc.
MARKET DYNAMICS
The rising geriatric population, rising investments from pharmaceutical and biopharmaceutical companies in research and development to design advanced drug delivery systems, rising healthcare expenditure and rising number of premature births are few major factors driving the controlled release drug delivery market. However there are few factors that may affect the controlled release drug delivery market negatively which include high dose of API requirement and controlled drug release systems are expensive in nature as compared to traditional pharmaceutical formulations.
MARKET SCOPE
The "Global Controlled Release Drug Delivery Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of controlled release drug delivery market with detailed market segmentation by technology, release mechanism, application and geography. The global controlled release drug delivery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading controlled release drug delivery market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global controlled release drug delivery market is segmented on the basis of technology, release mechanism and application. Based on technology, the market is segmented as Wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery, and others. On the basis of release mechanism, the global controlled release drug delivery market is segmented into activation modulated, micro reservoir feedback regulated, partition controlled, polymer matrix systems, and chemically activated systems. Based on application, the market is segmented into injectables, drug eluting stents, oral controlled, transdermal and ocular patches, infusion pumps, and metered dose inhalers.
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global controlled release drug delivery market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The controlled release drug delivery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting controlled release drug delivery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the controlled release drug delivery market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global controlled release drug delivery market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The controlled release drug delivery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting controlled release drug delivery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the controlled release drug delivery market in these regions.
MARKET PLAYERSThe reports cover key developments in the controlled release drug delivery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from controlled release drug delivery market are anticipated to lucrative growth opportunities in the future with the rising demand for controlled release drug delivery in the global market. Below mentioned is the list of few companies engaged in the controlled release drug delivery market.
The report also includes the profiles of key controlled release drug delivery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Orbis Biosciences, Inc.
- Merck and Co., Inc.
- Alkermes Plc.
- Johnson and Johnson
- Coating Place, Inc.
- Corium International, Inc.
- Depomed, Inc.
- Pfizer, Inc.
- Aradigm Corporation
- Capsugel
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Controlled Release Drug Delivery Market - By Technology
1.3.2 Controlled Release Drug Delivery Market - By Release Mechanism
1.3.3 Controlled Release Drug Delivery Market - By Application
1.3.4 Controlled Release Drug Delivery Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. CONTROLLED RELEASE DRUG DELIVERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CONTROLLED RELEASE DRUG DELIVERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CONTROLLED RELEASE DRUG DELIVERY MARKET - GLOBAL MARKET ANALYSIS
6.1. CONTROLLED RELEASE DRUG DELIVERY - GLOBAL MARKET OVERVIEW
6.2. CONTROLLED RELEASE DRUG DELIVERY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CONTROLLED RELEASE DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. WURSTER TECHNIQUE
7.3.1. Overview
7.3.2. Wurster technique Market Forecast and Analysis
7.4. COACERVATION
7.4.1. Overview
7.4.2. Coacervation Market Forecast and Analysis
7.5. MICRO ENCAPSULATION
7.5.1. Overview
7.5.2. Micro Encapsulation Market Forecast and Analysis
7.6. IMPLANTS
7.6.1. Overview
7.6.2. Implants Market Forecast and Analysis
7.7. TRANSDERMAL
7.7.1. Overview
7.7.2. Transdermal Market Forecast and Analysis
7.8. TARGETED DELIVERY
7.8.1. Overview
7.8.2. Targeted Delivery Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. CONTROLLED RELEASE DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - RELEASE MECHANISM
8.1. OVERVIEW
8.2. RELEASE MECHANISM MARKET FORECASTS AND ANALYSIS
8.3. ACTIVATION MODULATED
8.3.1. Overview
8.3.2. Activation Modulated Market Forecast and Analysis
8.4. MICRO RESERVOIR FEEDBACK REGULATED
8.4.1. Overview
8.4.2. Micro Reservoir Feedback Regulated Market Forecast and Analysis
8.5. PARTITION CONTROLLED
8.5.1. Overview
8.5.2. Partition Controlled Market Forecast and Analysis
8.6. POLYMER MATRIX SYSTEMS
8.6.1. Overview
8.6.2. Polymer Matrix Systems Market Forecast and Analysis
8.7. CHEMICALLY ACTIVATED SYSTEMS
8.7.1. Overview
8.7.2. Chemically Activated Systems Market Forecast and Analysis
9. CONTROLLED RELEASE DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. INJECTABLES
9.3.1. Overview
9.3.2. Injectables Market Forecast and Analysis
9.4. DRUG ELUTING STENTS
9.4.1. Overview
9.4.2. Drug Eluting Stents Market Forecast and Analysis
9.5. ORAL CONTROLLED
9.5.1. Overview
9.5.2. Oral Controlled Market Forecast and Analysis
9.6. TRANSDERMAL AND OCULAR PATCHES
9.6.1. Overview
9.6.2. Transdermal And Ocular Patches Market Forecast and Analysis
9.7. INFUSION PUMPS
9.7.1. Overview
9.7.2. Infusion Pumps Market Forecast and Analysis
9.8. METERED DOSE INHALERS
9.8.1. Overview
9.8.2. Metered Dose Inhalers Market Forecast and Analysis
10. CONTROLLED RELEASE DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Controlled Release Drug Delivery Market Overview
10.1.2 North America Controlled Release Drug Delivery Market Forecasts and Analysis
10.1.3 North America Controlled Release Drug Delivery Market Forecasts and Analysis - By Technology
10.1.4 North America Controlled Release Drug Delivery Market Forecasts and Analysis - By Release Mechanism
10.1.5 North America Controlled Release Drug Delivery Market Forecasts and Analysis - By Application
10.1.6 North America Controlled Release Drug Delivery Market Forecasts and Analysis - By Countries
10.1.6.1 United States Controlled Release Drug Delivery Market
10.1.6.1.1 United States Controlled Release Drug Delivery Market by Technology
10.1.6.1.2 United States Controlled Release Drug Delivery Market by Release Mechanism
10.1.6.1.3 United States Controlled Release Drug Delivery Market by Application
10.1.6.2 Canada Controlled Release Drug Delivery Market
10.1.6.2.1 Canada Controlled Release Drug Delivery Market by Technology
10.1.6.2.2 Canada Controlled Release Drug Delivery Market by Release Mechanism
10.1.6.2.3 Canada Controlled Release Drug Delivery Market by Application
10.1.6.3 Mexico Controlled Release Drug Delivery Market
10.1.6.3.1 Mexico Controlled Release Drug Delivery Market by Technology
10.1.6.3.2 Mexico Controlled Release Drug Delivery Market by Release Mechanism
10.1.6.3.3 Mexico Controlled Release Drug Delivery Market by Application
10.2. EUROPE
10.2.1 Europe Controlled Release Drug Delivery Market Overview
10.2.2 Europe Controlled Release Drug Delivery Market Forecasts and Analysis
10.2.3 Europe Controlled Release Drug Delivery Market Forecasts and Analysis - By Technology
10.2.4 Europe Controlled Release Drug Delivery Market Forecasts and Analysis - By Release Mechanism
10.2.5 Europe Controlled Release Drug Delivery Market Forecasts and Analysis - By Application
10.2.6 Europe Controlled Release Drug Delivery Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Controlled Release Drug Delivery Market
10.2.6.1.1 Germany Controlled Release Drug Delivery Market by Technology
10.2.6.1.2 Germany Controlled Release Drug Delivery Market by Release Mechanism
10.2.6.1.3 Germany Controlled Release Drug Delivery Market by Application
10.2.6.2 France Controlled Release Drug Delivery Market
10.2.6.2.1 France Controlled Release Drug Delivery Market by Technology
10.2.6.2.2 France Controlled Release Drug Delivery Market by Release Mechanism
10.2.6.2.3 France Controlled Release Drug Delivery Market by Application
10.2.6.3 Italy Controlled Release Drug Delivery Market
10.2.6.3.1 Italy Controlled Release Drug Delivery Market by Technology
10.2.6.3.2 Italy Controlled Release Drug Delivery Market by Release Mechanism
10.2.6.3.3 Italy Controlled Release Drug Delivery Market by Application
10.2.6.4 Spain Controlled Release Drug Delivery Market
10.2.6.4.1 Spain Controlled Release Drug Delivery Market by Technology
10.2.6.4.2 Spain Controlled Release Drug Delivery Market by Release Mechanism
10.2.6.4.3 Spain Controlled Release Drug Delivery Market by Application
10.2.6.5 United Kingdom Controlled Release Drug Delivery Market
10.2.6.5.1 United Kingdom Controlled Release Drug Delivery Market by Technology
10.2.6.5.2 United Kingdom Controlled Release Drug Delivery Market by Release Mechanism
10.2.6.5.3 United Kingdom Controlled Release Drug Delivery Market by Application
10.2.6.6 Rest of Europe Controlled Release Drug Delivery Market
10.2.6.6.1 Rest of Europe Controlled Release Drug Delivery Market by Technology
10.2.6.6.2 Rest of Europe Controlled Release Drug Delivery Market by Release Mechanism
10.2.6.6.3 Rest of Europe Controlled Release Drug Delivery Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Controlled Release Drug Delivery Market Overview
10.3.2 Asia-Pacific Controlled Release Drug Delivery Market Forecasts and Analysis
10.3.3 Asia-Pacific Controlled Release Drug Delivery Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Controlled Release Drug Delivery Market Forecasts and Analysis - By Release Mechanism
10.3.5 Asia-Pacific Controlled Release Drug Delivery Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Controlled Release Drug Delivery Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Controlled Release Drug Delivery Market
10.3.6.1.1 Australia Controlled Release Drug Delivery Market by Technology
10.3.6.1.2 Australia Controlled Release Drug Delivery Market by Release Mechanism
10.3.6.1.3 Australia Controlled Release Drug Delivery Market by Application
10.3.6.2 China Controlled Release Drug Delivery Market
10.3.6.2.1 China Controlled Release Drug Delivery Market by Technology
10.3.6.2.2 China Controlled Release Drug Delivery Market by Release Mechanism
10.3.6.2.3 China Controlled Release Drug Delivery Market by Application
10.3.6.3 India Controlled Release Drug Delivery Market
10.3.6.3.1 India Controlled Release Drug Delivery Market by Technology
10.3.6.3.2 India Controlled Release Drug Delivery Market by Release Mechanism
10.3.6.3.3 India Controlled Release Drug Delivery Market by Application
10.3.6.4 Japan Controlled Release Drug Delivery Market
10.3.6.4.1 Japan Controlled Release Drug Delivery Market by Technology
10.3.6.4.2 Japan Controlled Release Drug Delivery Market by Release Mechanism
10.3.6.4.3 Japan Controlled Release Drug Delivery Market by Application
10.3.6.5 South Korea Controlled Release Drug Delivery Market
10.3.6.5.1 South Korea Controlled Release Drug Delivery Market by Technology
10.3.6.5.2 South Korea Controlled Release Drug Delivery Market by Release Mechanism
10.3.6.5.3 South Korea Controlled Release Drug Delivery Market by Application
10.3.6.6 Rest of Asia-Pacific Controlled Release Drug Delivery Market
10.3.6.6.1 Rest of Asia-Pacific Controlled Release Drug Delivery Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Controlled Release Drug Delivery Market by Release Mechanism
10.3.6.6.3 Rest of Asia-Pacific Controlled Release Drug Delivery Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Controlled Release Drug Delivery Market Overview
10.4.2 Middle East and Africa Controlled Release Drug Delivery Market Forecasts and Analysis
10.4.3 Middle East and Africa Controlled Release Drug Delivery Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Controlled Release Drug Delivery Market Forecasts and Analysis - By Release Mechanism
10.4.5 Middle East and Africa Controlled Release Drug Delivery Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Controlled Release Drug Delivery Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Controlled Release Drug Delivery Market
10.4.6.1.1 South Africa Controlled Release Drug Delivery Market by Technology
10.4.6.1.2 South Africa Controlled Release Drug Delivery Market by Release Mechanism
10.4.6.1.3 South Africa Controlled Release Drug Delivery Market by Application
10.4.6.2 Saudi Arabia Controlled Release Drug Delivery Market
10.4.6.2.1 Saudi Arabia Controlled Release Drug Delivery Market by Technology
10.4.6.2.2 Saudi Arabia Controlled Release Drug Delivery Market by Release Mechanism
10.4.6.2.3 Saudi Arabia Controlled Release Drug Delivery Market by Application
10.4.6.3 U.A.E Controlled Release Drug Delivery Market
10.4.6.3.1 U.A.E Controlled Release Drug Delivery Market by Technology
10.4.6.3.2 U.A.E Controlled Release Drug Delivery Market by Release Mechanism
10.4.6.3.3 U.A.E Controlled Release Drug Delivery Market by Application
10.4.6.4 Rest of Middle East and Africa Controlled Release Drug Delivery Market
10.4.6.4.1 Rest of Middle East and Africa Controlled Release Drug Delivery Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Controlled Release Drug Delivery Market by Release Mechanism
10.4.6.4.3 Rest of Middle East and Africa Controlled Release Drug Delivery Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Controlled Release Drug Delivery Market Overview
10.5.2 South and Central America Controlled Release Drug Delivery Market Forecasts and Analysis
10.5.3 South and Central America Controlled Release Drug Delivery Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Controlled Release Drug Delivery Market Forecasts and Analysis - By Release Mechanism
10.5.5 South and Central America Controlled Release Drug Delivery Market Forecasts and Analysis - By Application
10.5.6 South and Central America Controlled Release Drug Delivery Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Controlled Release Drug Delivery Market
10.5.6.1.1 Brazil Controlled Release Drug Delivery Market by Technology
10.5.6.1.2 Brazil Controlled Release Drug Delivery Market by Release Mechanism
10.5.6.1.3 Brazil Controlled Release Drug Delivery Market by Application
10.5.6.2 Argentina Controlled Release Drug Delivery Market
10.5.6.2.1 Argentina Controlled Release Drug Delivery Market by Technology
10.5.6.2.2 Argentina Controlled Release Drug Delivery Market by Release Mechanism
10.5.6.2.3 Argentina Controlled Release Drug Delivery Market by Application
10.5.6.3 Rest of South and Central America Controlled Release Drug Delivery Market
10.5.6.3.1 Rest of South and Central America Controlled Release Drug Delivery Market by Technology
10.5.6.3.2 Rest of South and Central America Controlled Release Drug Delivery Market by Release Mechanism
10.5.6.3.3 Rest of South and Central America Controlled Release Drug Delivery Market by Application
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CONTROLLED RELEASE DRUG DELIVERY MARKET, KEY COMPANY PROFILES
12.1. ORBIS BIOSCIENCES, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK AND CO., INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ALKERMES PLC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JOHNSON AND JOHNSON
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. COATING PLACE, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CORIUM INTERNATIONAL, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. DEPOMED, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ARADIGM CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CAPSUGEL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Orbis Biosciences, Inc.
2. Merck and Co. , Inc.
3. Alkermes Plc.
4. Johnson and Johnson
5. Coating Place, Inc.
6. Corium International, Inc.
7. Depomed, Inc.
8. Pfizer, Inc.
9. Aradigm Corporation
10. Capsugel
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For